(the same as competitor Promescents VitaFLUX)
Weight-loss drug targets fat that endangers heart According to a study published by UTSW preventive cardiologist Parag Joshi, M.D., a once-daily dose of liraglutide combined with lifestyle interventions significantly lowered two types of fat that endanger heart health
if your diet quality declines, folate could become low
Proactive discussions with patients about coverage changes, access barriers, and documentation needs may help reduce treatment interruptions and support continuity of care
(Nasdaq: SKYE) (Skye), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the debut of its Anatomy of Progress nimacimab development update video series and availability of presentations related to the development of its anti-obesity drug, nimacimab, presented in multiple forums at the American Diabetes Associations (ADA) 85 th Scientific Sessions held June 20-23, 2025, in Chicago, Illinois